{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:01:23Z","timestamp":1792814483300,"version":"4.5.0"},"reference-count":114,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jaad.2022.01.053","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T11:29:06Z","timestamp":1644838146000},"page":"271-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Skin cancer: Primary, secondary, and tertiary prevention. Part II."],"prefix":"10.1016","volume":"87","author":[{"given":"Kristina D.","family":"Rojas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana E.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna J.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Penedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Jaimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jaad.2022.01.053_bib1","first-page":"195","article-title":"Secondary prevention strategies for nonmelanoma skin cancer","volume":"32","author":"Lopez","year":"2018","journal-title":"Oncology (Williston Park)"},{"issue":"4","key":"10.1016\/j.jaad.2022.01.053_bib2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.det.2017.06.001","article-title":"Clinical diagnosis of skin cancer: dnhancing inspection and early recognition","volume":"35","author":"Glazer","year":"2017","journal-title":"Dermatol Clin"},{"issue":"14","key":"10.1016\/j.jaad.2022.01.053_bib3","doi-asserted-by":"crossref","first-page":"E422","DOI":"10.1503\/cmaj.171154","article-title":"Consolidated principles for screening based on a systematic review and consensus process","volume":"190","author":"Dobrow","year":"2018","journal-title":"CMAJ"},{"issue":"3","key":"10.1016\/j.jaad.2022.01.053_bib4","first-page":"LE01","article-title":"Screening in public health and clinical care: similarities and differences in definitions, types, and aims\u2014a systematic review","volume":"11","author":"Speechley","year":"2017","journal-title":"J Clin Diagn Res"},{"issue":"5","key":"10.1016\/j.jaad.2022.01.053_bib5","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jaad.2016.07.009","article-title":"Who detects melanoma? Impact of detection patterns on characteristics and prognosis of patients with melanoma","volume":"75","author":"Aviles-Izquierdo","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/1097-0142(20000715)89:2<342::AID-CNCR19>3.0.CO;2-P","article-title":"Patterns of detection in patients with cutaneous melanoma","volume":"89","author":"Brady","year":"2000","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.jaad.2022.01.053_bib7","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1158\/1055-9965.EPI-09-0310","article-title":"Efficacy of skin self-examination practices for early melanoma detection","volume":"18","author":"Pollitt","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/ajd.12143","article-title":"\u2018Do UC the melanoma?\u2019 Recognising the importance of different lesions displaying unevenness or having a history of change for early melanoma detection","volume":"55","author":"Yagerman","year":"2014","journal-title":"Australas J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2022.01.053_bib10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.5694\/mja17.00123","article-title":"Clinical practice guidelines for the diagnosis and management of melanoma: melanomas that lack classical clinical features","volume":"207","author":"Mar","year":"2017","journal-title":"Med J Aust"},{"issue":"4","key":"10.1016\/j.jaad.2022.01.053_bib15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jaad.2015.01.025","article-title":"Early detection of melanoma: reviewing the ABCDEs","volume":"72","author":"Tsao","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2022.01.053_bib16","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.jaad.2020.07.014","article-title":"Interactive skin self-examination digital platforms for the prevention of skin cancer: a narrative literature review","volume":"84","author":"Sar-Graycar","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2022.01.053_bib17","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1001\/jama.2018.1623","article-title":"Behavioral counseling to prevent skin cancer: US Preventive Services Task Force recommendation statement","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jaad.2022.01.053_bib23","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/tri.13520","article-title":"Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines","volume":"32","author":"Crow","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.jaad.2022.01.053_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejca.2019.06.003","article-title":"Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines","volume":"118","author":"Peris","year":"2019","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.jaad.2022.01.053_bib26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jama.2016.8465","article-title":"Screening for skin cancer: US Preventive Services Task Force recommendation statement","volume":"316","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jaad.2022.01.053_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000096904","article-title":"Dermoscopy key points: recommendations from the international dermoscopy society","volume":"214","author":"Bowling","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2022.01.053_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejca.2019.11.014","article-title":"European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics\u2014Update 2019","volume":"126","author":"Garbe","year":"2020","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.jaad.2022.01.053_bib29","first-page":"145","article-title":"Accuracy of dermoscopy vs. visual inspection for diagnosing melanoma in adults","volume":"101","author":"Clebak","year":"2020","journal-title":"Am Fam Physician"},{"issue":"3","key":"10.1016\/j.jaad.2022.01.053_bib30","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaad.2019.09.046","article-title":"Consensus recommendations for the use of non-invasive melanoma detection techniques based on results of an international DELPHI process","volume":"85","author":"Waldman","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2022.01.053_bib31","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jaad.2017.10.007","article-title":"Guidelines of care for the management of cutaneous squamous cell carcinoma","volume":"78","author":"Alam","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2022.01.053_bib32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejca.2020.01.007","article-title":"European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: part 1. Epidemiology, diagnostics and prevention","volume":"128","author":"Stratigos","year":"2020","journal-title":"Eur J Cancer"},{"issue":"15","key":"10.1016\/j.jaad.2022.01.053_bib33","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1002\/cncr.26707","article-title":"Behavioral determinants of successful early melanoma detection: role of self and physician skin examination","volume":"118","author":"Swetter","year":"2012","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.jaad.2022.01.053_bib34","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1001\/jamaoncol.2016.6779","article-title":"A large skin cancer screening quality initiative: description and first-year outcomes","volume":"3","author":"Ferris","year":"2017","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib35","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ijc.24747","article-title":"Clinical whole-body skin examination reduces the incidence of thick melanomas","volume":"126","author":"Aitken","year":"2010","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.jaad.2022.01.053_bib36","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jaad.2007.10.648","article-title":"Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996","volume":"58","author":"Schneider","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5826\/dpc.0902a09","article-title":"Total body skin examination practices: a survey study amongst dermatologists at high-risk skin cancer clinics","volume":"9","author":"Bajaj","year":"2019","journal-title":"Dermatol Pract Concept"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/CCO.0000000000000611","article-title":"Use of noninvasive imaging in the management of skin cancer","volume":"32","author":"Giuffrida","year":"2020","journal-title":"Curr Opin Oncol"},{"issue":"12","key":"10.1016\/j.jaad.2022.01.053_bib39","article-title":"Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults","volume":"12","author":"Dinnes","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.jaad.2022.01.053_bib40","article-title":"Visual inspection and dermoscopy, alone or in combination, for diagnosing keratinocyte skin cancers in adults","volume":"12","author":"Dinnes","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.jaad.2022.01.053_bib41","article-title":"Squamous cell carcinoma: an update on diagnosis and treatment","volume":"10","author":"Combalia","year":"2020","journal-title":"Dermatol Pract Concept"},{"issue":"8","key":"10.1016\/j.jaad.2022.01.053_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027529","article-title":"Dermoscopy for melanoma detection and triage in primary care: a systematic review","volume":"9","author":"Jones","year":"2019","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.jaad.2022.01.053_bib43","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3390\/ijerph18041726","article-title":"The value of total body photography for the early detection of melanoma: a systematic review","volume":"18","author":"Hornung","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"10.1016\/j.jaad.2022.01.053_bib44","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jaad.2020.03.121","article-title":"Technological advances for the detection of melanoma: advances in diagnostic techniques","volume":"83","author":"Fried","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib45","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/pcmr.12907","article-title":"The role of technology in melanoma screening and diagnosis","volume":"34","author":"Young","year":"2021","journal-title":"Pigment Cell Melanoma Res"},{"issue":"3","key":"10.1016\/j.jaad.2022.01.053_bib46","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaad.2019.07.016","article-title":"Computer algorithms show potential for improving dermatologists\u2019 accuracy to diagnose cutaneous melanoma: results of the International Skin Imaging Collaboration 2017","volume":"82","author":"Marchetti","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2022.01.053_bib49","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.bjps.2010.07.006","article-title":"Revised UK guidelines for the management of cutaneous melanoma 2010","volume":"63","author":"Marsden","year":"2010","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"3","key":"10.1016\/j.jaad.2022.01.053_bib50","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.det.2019.02.004","article-title":"Topical and systemic modalities for chemoprevention of nonmelanoma skin cancer","volume":"37","author":"Nemer","year":"2019","journal-title":"Dermatol Clin"},{"issue":"3","key":"10.1016\/j.jaad.2022.01.053_bib51","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14892","article-title":"Oral nicotinamide: the role in skin cancer chemoprevention","volume":"34","author":"Giacalone","year":"2021","journal-title":"Dermatol Ther"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib52","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jaad.2020.04.160","article-title":"Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: systematic review and meta-analyses","volume":"84","author":"Tee","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2022.01.053_bib53","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/jid.2011.483","article-title":"Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial","volume":"132","author":"Weinstock","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib54","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamadermatol.2017.3631","article-title":"Chemoprevention of basal and squamous cell carcinoma with a single course of fluorouracil, 5%, cream: a randomized clinical trial","volume":"154","author":"Weinstock","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2022.01.053_bib55","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/jdv.15868","article-title":"Long-term clinical outcomes of imiquimod 5% cream vs. diclofenac 3% gel for actinic keratosis on the face or scalp: a pooled analysis of two randomized controlled trials","volume":"34","author":"Gollnick","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"17","key":"10.1016\/j.jaad.2022.01.053_bib56","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","article-title":"A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention","volume":"373","author":"Chen","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jaad.2022.01.053_bib57","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/jid.2011.459","article-title":"Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials","volume":"132","author":"Surjana","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2022.01.053_bib58","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/bjd.14662","article-title":"A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients","volume":"175","author":"Chen","year":"2016","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2022.01.053_bib59","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1002\/cncr.26374","article-title":"Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251)","volume":"118","author":"Kadakia","year":"2012","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.jaad.2022.01.053_bib60","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1440-0960.2002.00613.x","article-title":"Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients","volume":"43","author":"George","year":"2002","journal-title":"Australas J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2022.01.053_bib61","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1200\/JCO.1995.13.8.1933","article-title":"Prevention\u00a0of skin cancer and reduction of keratotic skin\u00a0lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study","volume":"13","author":"Bavinck","year":"1995","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.jaad.2022.01.053_bib62","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1002\/cncr.30920","article-title":"Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590)","volume":"123","author":"Bhatia","year":"2017","journal-title":"Cancer"},{"issue":"24","key":"10.1016\/j.jaad.2022.01.053_bib63","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/jnci\/djq442","article-title":"Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial","volume":"102","author":"Elmets","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.jaad.2022.01.053_bib64","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1158\/1940-6207.CAPR-09-0200","article-title":"Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+\/- humans and mice","volume":"3","author":"Tang","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"10.1016\/j.jaad.2022.01.053_bib65","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1056\/NEJMsb2019760","article-title":"The rapid rise in cutaneous melanoma diagnoses","volume":"384","author":"Welch","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jaad.2022.01.053_bib66","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.clindermatol.2009.06.021","article-title":"Melanoma epidemic: facts and controversies","volume":"28","author":"Erickson","year":"2010","journal-title":"Clin Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2022.01.053_bib68","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0001-7310(05)73073-8","article-title":"Euromelanoma day. Results of the 2000, 2001 and 2002 campaigns in Spain. Article in Spanish","volume":"96","author":"Conejo-Mir","year":"2005","journal-title":"Actas Dermosifiliogr"},{"issue":"1","key":"10.1016\/j.jaad.2022.01.053_bib69","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1468-3083.2006.01865.x","article-title":"Melanoma\/skin cancer screening in a Mediterranean country: results of the Euromelanoma Screening Day Campaign in Greece","volume":"21","author":"Stratigos","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.jaad.2022.01.053_bib70","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-4632.2012.05783.x","article-title":"The Italian Euromelanoma Day: evaluation of results and implications for future prevention campaigns","volume":"53","author":"Suppa","year":"2014","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib71","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jaad.2010.11.016","article-title":"Systematic skin cancer screening in Northern Germany","volume":"66","author":"Breitbart","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2022.01.053_bib72","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/cncr.29755","article-title":"Does skin cancer screening save lives? A\u00a0detailed analysis of mortality time trends in Schleswig-Holstein and Germany","volume":"122","author":"Stang","year":"2016","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.jaad.2022.01.053_bib73","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008158","article-title":"Melanoma mortality following skin cancer screening in Germany","volume":"5","author":"Boniol","year":"2015","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.jaad.2022.01.053_bib74","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5826\/dpc.0704a13","article-title":"Examining the factors associated with past and present dermoscopy use among family physicians","volume":"7","author":"Morris","year":"2017","journal-title":"Dermatol Pract Concept"},{"issue":"6","key":"10.1016\/j.jaad.2022.01.053_bib75","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3122\/jabfm.2020.06.200238","article-title":"Perspectives on dermoscopy in the primary care setting","volume":"33","author":"Williams","year":"2020","journal-title":"J Am Board Fam Med"},{"issue":"4","key":"10.1016\/j.jaad.2022.01.053_bib76","first-page":"283","article-title":"Skin cancer prevention","volume":"11","author":"Kornek","year":"2013","journal-title":"J Dtsch Dermatol Ges"},{"issue":"11","key":"10.1016\/j.jaad.2022.01.053_bib77","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1089\/acm.2018.0193","article-title":"Comprehensive lifestyle modification intervention to improve chronic disease risk factors and quality of life in cancer survivors","volume":"24","author":"Golubic","year":"2018","journal-title":"J Altern Complement Med"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib78","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0040-1709142","article-title":"Mohs surgery versus standard local excision for basal cell carcinoma, squamous cell carcinoma, and melanoma skin cancer","volume":"36","author":"Johnson","year":"2020","journal-title":"Facial Plast Surg"},{"issue":"1","key":"10.1016\/j.jaad.2022.01.053_bib79","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.fsc.2018.08.005","article-title":"Radiotherapy for skin cancers of the face, head, and neck","volume":"27","author":"Mierzwa","year":"2019","journal-title":"Facial Plast Surg Clin North Am"},{"issue":"4","key":"10.1016\/j.jaad.2022.01.053_bib80","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.det.2019.05.002","article-title":"Review and update on evidence-based surgical treatment recommendations for nonmelanoma skin cancer","volume":"37","author":"Shelton","year":"2019","journal-title":"Dermatol Clin"},{"issue":"4","key":"10.1016\/j.jaad.2022.01.053_bib81","doi-asserted-by":"crossref","first-page":"364","DOI":"10.6004\/jnccn.2021.0018","article-title":"NCCN guidelines(R) insights: melanoma: cutaneous, version 2.2021","volume":"19","author":"Swetter","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.jaad.2022.01.053_bib82","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaad.2018.08.055","article-title":"Guidelines of care for the management of primary cutaneous melanoma","volume":"80","author":"Swetter","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2022.01.053_bib89","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejca.2019.11.015","article-title":"European consensus-based interdisciplinary guideline for melanoma. Part 2: treatment\u2014update 2019","volume":"126","author":"Garbe","year":"2020","journal-title":"Eur J Cancer"},{"issue":"14","key":"10.1016\/j.jaad.2022.01.053_bib90","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.ejca.2015.06.110","article-title":"Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline","volume":"51","author":"Stratigos","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaad.2022.01.053_bib91","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejca.2020.01.008","article-title":"European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: part 2. Treatment","volume":"128","author":"Stratigos","year":"2020","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.jaad.2022.01.053_bib92","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.suc.2014.07.003","article-title":"Surviving cutaneous melanoma: a clinical review of follow-up practices, surveillance, and management of recurrence","volume":"94","author":"Mrazek","year":"2014","journal-title":"Surg Clin North Am"},{"issue":"3","key":"10.1016\/j.jaad.2022.01.053_bib93","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28090","article-title":"Prevalence and correlates of adherence to skin examination among adolescent and young adult survivors of melanoma from the Project Forward Study","volume":"67","author":"Miller","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.jaad.2022.01.053_bib94","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/cncr.30985","article-title":"Survivorship care planning in skin cancer: an unbiased statistical approach to identifying patterns of care-plan use","volume":"124","author":"Benci","year":"2018","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib96","first-page":"139","article-title":"Measuring quality of life in patients with melanoma: development of the FACT-melanoma subscale","volume":"3","author":"Cormier","year":"2005","journal-title":"J Support Oncol"},{"issue":"7","key":"10.1016\/j.jaad.2022.01.053_bib98","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/01.MLG.0000166177.98414.5E","article-title":"Creation of a quality of life instrument for nonmelanoma skin cancer patients","volume":"115","author":"Rhee","year":"2005","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib99","first-page":"1005","article-title":"Psychosocial distress in patients with cutaneous melanoma: validation of the skin cancer index (SCI)","volume":"29","author":"Moran","year":"2021","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF00434740","article-title":"Basal cell carcinomas cause little handicap","volume":"5","author":"Blackford","year":"1996","journal-title":"Qual Life Res"},{"issue":"3","key":"10.1016\/j.jaad.2022.01.053_bib101","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2310\/7750.2008.07034","article-title":"Measurement of utility in nonmelanoma skin cancer","volume":"12","author":"Lear","year":"2008","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib102","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/archotol.130.2.141","article-title":"Quality of life and sun-protective behavior in patients with skin cancer","volume":"130","author":"Rhee","year":"2004","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib103","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000502033","article-title":"Health-related quality of life, satisfaction with care, and cosmetic results in relation to treatment among patients with keratinocyte cancer in the head and neck area: results from the PROFILES registry","volume":"236","author":"Arts","year":"2020","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib104","first-page":"129","article-title":"Quality of life in health care of non-melanoma skin cancer\u2014results of a pilot study","volume":"9","author":"Steinbauer","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"10.1016\/j.jaad.2022.01.053_bib105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1188\/14.ONF.57-65","article-title":"Nonmelanoma skin cancer: disease-specific quality-of-life concerns and distress","volume":"41","author":"Radiotis","year":"2014","journal-title":"Oncol Nurs Forum"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib106","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1684\/ejd.2019.3523","article-title":"Comparison of quality of life between melanoma and non-melanoma skin cancer patients","volume":"29","author":"Sampogna","year":"2019","journal-title":"Eur J Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2022.01.053_bib107","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/pon.4366","article-title":"Fear of new or recurrent melanoma after treatment for localised melanoma","volume":"26","author":"Bell","year":"2017","journal-title":"Psychooncology"},{"key":"10.1016\/j.jaad.2022.01.053_bib108","doi-asserted-by":"crossref","first-page":"2041872","DOI":"10.1155\/2017\/2041872","article-title":"A qualitative study of quality of life concerns following a melanoma diagnosis","volume":"2017","author":"Vogel","year":"2017","journal-title":"J Skin Cancer"},{"issue":"11","key":"10.1016\/j.jaad.2022.01.053_bib109","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/pon.4290","article-title":"Systematic review of psychosocial outcomes for patients with advanced melanoma","volume":"26","author":"Dunn","year":"2017","journal-title":"Psychooncology"},{"key":"10.1016\/j.jaad.2022.01.053_bib110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejca.2016.10.008","article-title":"A systematic review examining factors influencing health related quality of life among melanoma cancer survivors","volume":"69","author":"Hamel","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaad.2022.01.053_bib111","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejca.2017.07.052","article-title":"Health-related quality of life in melanoma patients: impact of melanoma-related limb lymphoedema","volume":"85","author":"Gjorup","year":"2017","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.jaad.2022.01.053_bib112","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s11764-019-00770-0","article-title":"The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors","volume":"13","author":"Lai-Kwon","year":"2019","journal-title":"J Cancer Surviv"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib113","first-page":"561","article-title":"An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors","volume":"28","author":"O'Reilly","year":"2020","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.jaad.2022.01.053_bib114","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jaad.2016.04.031","article-title":"Oncofertility considerations in adolescents and young adults given a diagnosis of melanoma: fertility risk of Food and Drug Administration-approved systemic therapies","volume":"75","author":"Walter","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/pbc.22001","article-title":"Patient attitudes toward fertility preservation","volume":"53","author":"Schover","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.jaad.2022.01.053_bib116","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaad.2018.06.068","article-title":"Sun protection behavior after diagnosis of high-risk primary melanoma and risk of a subsequent primary","volume":"80","author":"von Schuckmann","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2022.01.053_bib117","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1440-0960.2010.00674.x","article-title":"Risk factors in a cohort of patients with multiple primary melanoma","volume":"51","author":"McMeniman","year":"2010","journal-title":"Australas J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2022.01.053_bib118","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10865-006-9064-5","article-title":"Prevalence and correlates of sun protection and skin self-examination practices among cutaneous malignant melanoma survivors","volume":"29","author":"Manne","year":"2006","journal-title":"J Behav Med"},{"issue":"6","key":"10.1016\/j.jaad.2022.01.053_bib119","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00432-015-2086-z","article-title":"Skin cancer prevention practices among malignant melanoma survivors: a systematic review","volume":"142","author":"Nahar","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"10.1016\/j.jaad.2022.01.053_bib120","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1158\/1055-9965.EPI-16-0854","article-title":"Sun exposure and protection behaviors among long-term melanoma survivors and population controls","volume":"26","author":"Vogel","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.jaad.2022.01.053_bib121","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/CMR.0b013e3280112b98","article-title":"Sun-related behavior after a diagnosis of cutaneous malignant melanoma","volume":"17","author":"Lee","year":"2007","journal-title":"Melanoma Res"},{"issue":"10","key":"10.1016\/j.jaad.2022.01.053_bib122","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/pon.1510","article-title":"Sun protection and skin self-examination in melanoma survivors","volume":"18","author":"Mujumdar","year":"2009","journal-title":"Psychooncology"},{"issue":"1","key":"10.1016\/j.jaad.2022.01.053_bib123","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.jaad.2010.10.002","article-title":"Sun-protection behaviors of melanoma survivors","volume":"66","author":"Mayer","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib124","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/bjd.12066","article-title":"Sun behaviour after cutaneous malignant melanoma: a study based on ultraviolet radiation measurements and sun diary data","volume":"168","author":"Idorn","year":"2013","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib125","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jamadermatol.2013.5098","article-title":"A\u00a03-year follow-up of sun behavior in patients with cutaneous malignant melanoma","volume":"150","author":"Idorn","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2022.01.053_bib126","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00403-020-02163-1","article-title":"Sun exposure reduction by melanoma survivors with wearable sensor providing real-time UV exposure and daily text messages with structured goal setting","volume":"313","author":"Robinson","year":"2021","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"10.1016\/j.jaad.2022.01.053_bib127","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/jayao.2016.0092","article-title":"Using appearance-based messages to increase sun protection in adolescent young adult cancer survivors: a pilot study of ultraviolet light photography","volume":"6","author":"Recklitis","year":"2017","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib128","first-page":"174","article-title":"Self-efficacy and comfort with partner-assisted skin examination in patients receiving follow-up care for melanoma","volume":"32","author":"DiMillo","year":"2017","journal-title":"Health Educ Res"},{"issue":"1","key":"10.1016\/j.jaad.2022.01.053_bib129","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1111\/ajd.12877","article-title":"Remote partner assisted skin self-examination skills training of melanoma survivors and their partners","volume":"60","author":"Robinson","year":"2019","journal-title":"Australas J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2022.01.053_bib130","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/jamadermatol.2015.2819","article-title":"Influence of quality of relationship between patient with melanoma and partner on partner-assisted skin examination education: a randomized clinical trial","volume":"152","author":"Hultgren","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2022.01.053_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-6476-5","article-title":"Short and long-term barriers and facilitators of skin self-examination among individuals diagnosed with melanoma","volume":"20","author":"Coroiu","year":"2020","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.jaad.2022.01.053_bib132","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.3390\/jcm9092969","article-title":"Feasibility and acceptability of fear-less: A stepped-care program to manage fear of cancer recurrence in people with metastatic melanoma","volume":"9","author":"Lynch","year":"2020","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.jaad.2022.01.053_bib133","first-page":"4849","article-title":"\u201cMelanoma: questions and answers.\u201d Development and evaluation of a psycho-educational resource for people with a history of melanoma","volume":"24","author":"Kasparian","year":"2016","journal-title":"Support Care Cancer"},{"issue":"36","key":"10.1016\/j.jaad.2022.01.053_bib134","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1200\/JCO.2016.68.2278","article-title":"Psychoeducational intervention to reduce fear of cancer recurrence in people at high risk of developing another primary melanoma: results of a randomized controlled trial","volume":"34","author":"Dieng","year":"2016","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.jaad.2022.01.053_bib135","doi-asserted-by":"crossref","first-page":"7301","DOI":"10.1002\/cam4.3299","article-title":"Remote skin self-examination training of melanoma survivors and their skin check partners: a randomized trial and comparison with in-person training","volume":"9","author":"Robinson","year":"2020","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.jaad.2022.01.053_bib136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-019-3453-x","article-title":"Achieving Self-Directed Integrated Cancer Aftercare (ASICA) in melanoma: protocol for a randomised patient-focused pilot\u00a0trial of delivering the ASICA intervention as a means\u00a0to earlier detection of recurrent and second primary\u00a0melanoma","volume":"20","author":"Murchie","year":"2019","journal-title":"Trials"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222002663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222002663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:05:00Z","timestamp":1759273500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962222002663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":114,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0190962222002663"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2022.01.053","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin cancer: Primary, secondary, and tertiary prevention. Part II.","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2022.01.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(22)01035-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}